Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage.
about
High-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: a meta-analysisEffects of preoperative proton pump inhibitor administration on bleeding after gastric endoscopic submucosal dissection: A systematic review and meta-analysisSecond-look endoscopy and factors associated with delayed bleeding after endoscopic submucosal dissectionPantoprazole for the treatment of peptic ulcer bleeding and prevention of rebleedingIntravenous omeprazole after endoscopic treatment of bleeding peptic ulcersIntermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis.Intravenous pantoprazole as an adjuvant therapy following successful endoscopic treatment for peptic ulcer bleeding.Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values.Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding.How evidence-based are current guidelines for managing patients with peptic ulcer bleeding?Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled TrialA head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots.High Dose versus Low Dose Intravenous Pantoprazole in Bleeding Peptic Ulcer: A Randomized Clinical TrialTranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding.Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy.Inhibition of gastric secretion and motility by simulated upper gastrointestinal haemorrhage: a response to facilitate haemostasis?Use of automatic computerised pump to maintain constant intragastric pH.Enhanced gastric mucosal haemostasis after upper gastrointestinal haemorrhageEnhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine.Pharmacological manipulation of gastric juice: thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage.Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage.Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.Clot lysis by gastric juice: an in vitro studyIntravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits.Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysisComparison of oral and intravenous proton pump inhibitor on patients with high risk bleeding peptic ulcers: a prospective, randomized, controlled clinical trial.Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers.Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis.Management of gastrointestinal hemorrhage.Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosisCimetidine therapy does not prevent rebleeding from peptic ulceration.Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patientsA prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissectionVonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers.Effects of esomeprazole on the healing process of post-endoscopic submucosal dissection gastric ulcers: a single arm, prospective trial.Role of proton pump inhibitors in the management of peptic ulcer bleeding.NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies
P2860
Q24605656-775284FC-746A-4B9A-80F7-031DA8D1CF48Q26766357-3135167D-040D-4BE2-BD49-1F87E0F9F89DQ26767105-3C6E5BFB-AE03-4669-8B20-3DA4D07608DFQ27025841-27BB5B16-9E74-4B19-846F-D743D1393B94Q28361594-0A1D1F22-5832-48BB-8391-F1C890A129F3Q30645995-C9FC9EC3-6165-4AB0-A947-6FF8D57631B4Q33431292-0D782D32-0AD0-4D97-80C7-4E873696C8C8Q33480299-6710AC8E-3EAA-4F12-9A00-E432C1181A42Q33617657-07C1BA61-B65D-4F1F-A370-FE97C19215C3Q33692802-9793F112-1200-45D1-B529-F62246EF3B88Q33772529-3DFBA2EF-7EF8-4232-9D34-4AC82DBB4C97Q33849286-6CF3BBFD-72BD-46DD-AD32-CEA2BEE3144BQ33866733-EA1CA04C-F9EE-40B8-8099-69B02D69D2D9Q33993009-1ACC9762-B1BE-4FFD-BBBC-82A553EDE047Q34067830-CA1B6E38-F9D2-451E-8315-B6AEF0DD5803Q34210779-1EE6B12A-E64F-494C-BC6A-7992E29FBFFBQ34297884-C2E995AF-7082-4195-BF71-3F90C88F99DEQ34391610-6D37DDAE-0322-4174-B43E-0FA2810C31E2Q34393017-8AF415AB-49FE-46A8-A02C-56D8D6EA061DQ34394183-61CBAE31-C21F-45CF-9E18-0DEFA747390AQ34397993-74F70448-FB71-4055-ADCA-89CEE8E0FC42Q34407674-A02817F1-B3AE-468D-9B12-630DF7F14D1DQ34427247-6449A711-3887-4B6C-B588-D6BAB6009900Q34526502-42E66F40-E357-4ED3-8ADA-B19B01F1FAD9Q34529738-D9FC2E2A-A320-49A5-9A7E-EDB259281C19Q34671092-E00BAF4F-D015-4535-BEB5-36F66E8F6E01Q34735634-ED025A2B-F45F-4111-A174-FC2CEDA7C248Q35024907-98E97DFD-25A8-44FC-960B-12F41FC998D8Q36022469-332F0D61-2D43-4AA1-A004-114D2A125FD6Q36180419-57119DBD-A761-48D5-B013-1374805006B0Q36274916-E8D28C42-76F6-439F-B719-4DDD87C930C8Q36285464-F1FB29EB-46DB-49D8-9C8E-7F58709AC094Q36422838-F2841E6C-03D8-4EE9-87B4-9C32FA71A883Q36705450-D48F5992-A426-441C-ADE1-53F6DBF0073FQ37161518-8DE75714-F099-45F8-9F6E-8EAA4EC4BCF8Q37223111-3A6C9940-543E-4D04-8DDD-27CE6A322590Q37421468-B2B2E519-0C63-4696-A9F9-EA3118D793A2Q37479404-6DB9CEA3-8010-4BD0-9FF4-3551B81F0878Q37876202-03C67376-166D-46F3-B088-3C03F2E80A20Q37882741-645AAD48-F4A1-439A-936A-F21138E18EDA
P2860
Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage.
description
1978 nî lūn-bûn
@nan
1978 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Effect of acid and pepsin on b ...... roduodenal mucosal hemorrhage.
@ast
Effect of acid and pepsin on b ...... roduodenal mucosal hemorrhage.
@en
Effect of acid and pepsin on b ...... roduodenal mucosal hemorrhage.
@nl
type
label
Effect of acid and pepsin on b ...... roduodenal mucosal hemorrhage.
@ast
Effect of acid and pepsin on b ...... roduodenal mucosal hemorrhage.
@en
Effect of acid and pepsin on b ...... roduodenal mucosal hemorrhage.
@nl
prefLabel
Effect of acid and pepsin on b ...... roduodenal mucosal hemorrhage.
@ast
Effect of acid and pepsin on b ...... roduodenal mucosal hemorrhage.
@en
Effect of acid and pepsin on b ...... roduodenal mucosal hemorrhage.
@nl
P2093
P1433
P1476
Effect of acid and pepsin on b ...... roduodenal mucosal hemorrhage.
@en
P2093
P407
P577
1978-01-01T00:00:00Z